ArticleJBRA assisted reproduction2026
Zingerone Mitigates Testicular Dysfunction Induced by Cisplatin.
Article in JBRA assisted reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCisplatin is one of the most widely used antitumor drugs globally, particularly in treating various solid tumors. The reproductive system is impacted by cisplatin toxic effects. This study aims to understand how Zingerone affects spermatogenesis defects in mice.
methodsIn the present experimental laboratory study, the 48 male NMRI mice (6 to 8 weeks of age, 25 to 30g weight) were treated with Cisplatin (7 mg/kg) for 5 days and zingerone for 30 days at concentrations of 10, 20, and 40 mg/kg before cisplatin administration. After the treatment period, the testicles were dissected immediately following sacrifice. Morphometric parameters, serum testosterone concentration, histology, Bax/Bcl-2 ratio, and testis weight have been assessed. To determine levels of oxidative stress, malondialdehyde contents and antioxidant levels were evaluated.
resultsCisplatin-induced structural damages enhanced the Bax/Bcl-2 ratio, and reduced testosterone levels and testis weight. Cisplatin caused oxidative stress by enhancing malondialdehyde contents in the mouse testicles. Zingerone dose-dependently reduced the Bax/Bcl-2 ratio and reversed the histological changes, testosterone levels, and antioxidant capacity.
conclusionsAccording to the results of the present study, Pretreatment with zingerone can improve testosterone production by preventing apoptosis and oxidative stress in the testicles of mice that have undergone cisplatin intoxication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.